However, a recent study found no correlation between the TP53 Arg72Pro polymorphism and CRC risk, with no significant differences in genotype and allele frequencies across sex, age, histological grade, tumor stage, smoking status, or alcohol consumption (12). The gene discussed is TP53; the disease is neoplasm.